MedAware Overview
MedAware has developed a medication safety monitoring platform that identifies patient- and provider-specific risks that might otherwise be missed by existing tools and systems. MedAware’s AI engine is used to provide a personalized look at the appropriateness of a patient’s medication therapy at each stage of their treatment journey, identifying prescribing anomalies that could put the patient, provider, care team, and health institution at risk. MedAware’s AI engine is powered by advanced machine-learning algorithms and outlier-detection mechanisms similar to those trusted by financial institutions for monitoring fraud detection.
Cumulative Funding Raised Over Time ($)
$8.0MAug 2017
$13.0MAug 2020
$13.0MAug 2025
$14.3MJan 2016
$17.8MJul 2019
$19.3MNov 2018
$20.3MOct 2014
$21.1MSep 2013
$21.1MSep 2024
Latest News
growth-positive
/PRNewswire/ -- Ballad Health, the leading healthcare provider in the Appalachian Highlands, has begun leveraging MedAware's AI-powered medication safety...
Ballad Health, a leading healthcare provider in the Appalachian Highlands, has integrated MedAwares AI-powered medication safety monitoring platform into its Epic pharmacy workflow. This partnership, announced in July 2023, aims to enhance patient safety by providing real-time, personalized risk monitoring for acute care patients. The platform allows pharmacists to proactively address medication-related risks, improving patient outcomes and operational efficiency. MedAwares technology has enabled Ballad Health to act on over 70% of identified patient risks, significantly surpassing previous systems. This collaboration highlights Ballad Healths commitment to innovation in rural healthcare and medication safety.
Partners
growth-positive
MedAware Validates an Emerging Risk to Patient Safety - Physician Burnout and Lack of Experience Linked to Prescription Errors
MedAware, a leader in AI-enabled decision support and patient safety solutions, released the results from a study showing that sleep-deprived, overworked junior physicians are at increased risk of erroneous prescribing and jeopardizing patient safety. The study highlights the need for AI-driven, personalized decision support to mitigate the risks of medication errors. MedAwares platform, which boasts an 85% accuracy rate, acts as a safety layer within electronic health records (EHRs) and detects outlier prescribing behavior. The study found that physicians with high workloads were 8 times more likely to make prescribing errors, and continuous back-to-back shifts were associated with 2 times the risk of error. MedAware emphasizes the importance of incorporating probabilistic and personalized decision support tools to improve patient safety.
Customers
growth-positive
Israeli tech catches medical mistakes before they happen
A machine learning-based patient safety solution from MedAware flagged potential errors and adverse drug events in the records of patients treated in outpatient clinics. The system performed well in identifying medication-related errors and implementing it could result in substantial cost savings. Prescription drug errors result in healthcare costs estimated at more than $20 billion annually in the United States.
Customers
growth-positive
Harvard Researchers Find Significant Clinical Impact and Savings with MedAware's Patient Safety Platform
MedAware, a developer of AI-based patient safety solutions, has published a study validating the clinical impact and cost savings of its machine learning-enabled clinical decision support platform. The study found that 70% of MedAwares AI-enabled clinical interventions would not have been generated by existing tools. If the system had been operational, it could have saved over $1.3 million in direct healthcare-related costs for adverse events potentially prevented in Massachusetts General and Brigham and Womens Hospitals outpatient clinics. The study analyzed outpatient data from two academic medical centers and found that MedAwares warnings were accurate, clinically valid, and would not have been flagged by existing decision support systems. The study highlights the potential of MedAwares platform to improve patient safety and drive cost savings in healthcare systems.
Customers
growth-positive
Assuta Ashdod Medical Center Deploys MedAware's Patient Safety Platform
MedAwares AI-based patient safety solution will be deployed in Assuta Ashdod, Israels newest hospital. The live implementation follows a successful trial deployment and will provide an essential layer of protection to prevent medical errors and faulty prescriptions. The system has been proven to be effective in identifying medication-related risks and preventing patient harm. MedAware aims to protect 100 percent of the Israeli population and transform patient safety globally.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $20.87M |
| Last funding | Undisclosed |
| Stage | C |
| Rounds | 12 |
| Investors | 8 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | www.medaware.com |
| Careers | Careers page |
| App Store | App Store |
Locations
10 Zarhin Street, Ra'anana, Israel
Photos & Videos
2 item(s)
MedAware Business
Business models
B2B
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersFinancial ServicesFinancial ProductsInsuranceCore Technology
Artificial IntelligenceMachine LearningTags (23)
clinical-trialspatent-pendingmedicationhealthcare-providersrisk-managementalert-systemdigital-healthcaremachine-learningdrugs-managementemrdata-analyticsdecision-makingmedical-datapharma-companiesartificial-intelligencedoctorsinsurance-companieshospitalsmobile-applicationsdecision-supportsafetycrowdsourcingbig-data-analyticsGeographic Markets
ChinaUnited StatesIsraelMedAware Financials
$20.87M
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
C
Funding stage
12
Total rounds
8
Investors
Cumulative Funding Raised Over Time ($)
$8.0MAug 2017
$13.0MAug 2020
$13.0MAug 2025
$14.3MJan 2016
$17.8MJul 2019
$19.3MNov 2018
$20.3MOct 2014
$21.1MSep 2013
$21.1MSep 2024
Private Equity Funding
Convertible Debt
Aug 2025
Undisclosed
OurCrowd
Undisclosed Round
Sep 2024
Undisclosed
OurCrowd
C Round
Aug 2020
$5M
OurCrowd (Lead)
Convertible Debt
Jul 2019
$3.5M
OurCrowd (Lead)
Convertible Debt
Nov 2018
$1.5M
OurCrowd (Lead)
A Round
Aug 2017
$8M
Gefen Capital, Becton, Dickinson and Company, Qure Ventures, Forbon Technology, OurCrowd
Debt Financing
Jan 2016
$1.3M
OurCrowd, Undisclosed Investor(s), WInton Capital
Seed
Oct 2014
$1M
OurCrowd, GE Ventures
Pre-Seed
Sep 2013
$800K
Undisclosed Investor(s)
Non-Equity Funding
GrantEvent
May 2017
$56K
EU Horizon 2020
GrantEvent
Jun 2016
$700K
BIRD Foundation
GrantEvent
Dec 2015
$310K
Office of the Chief Scientist
MedAware Lifecycle
Cumulative Funding Raised Over Time
$8.0MAug 2017
$13.0MAug 2020
$13.0MAug 2025
$14.3MJan 2016
$17.8MJul 2019
$19.3MNov 2018
$20.3MOct 2014
$21.1MSep 2013
$21.1MSep 2024
All Events
Convertible Debt
Aug 2025
Undisclosed
OurCrowd
Undisclosed Round
Sep 2024
Undisclosed
OurCrowd
C Round
Aug 2020
$5M
OurCrowd (Lead)
Convertible Debt
Jul 2019
$3.5M
OurCrowd (Lead)
Convertible Debt
Nov 2018
$1.5M
OurCrowd (Lead)
A Round
Aug 2017
$8M
Gefen Capital, Becton, Dickinson and Company, Qure Ventures, Forbon Technology, OurCrowd
Debt Financing
Jan 2016
$1.3M
OurCrowd, Undisclosed Investor(s), WInton Capital
Seed
Oct 2014
$1M
OurCrowd, GE Ventures
Pre-Seed
Sep 2013
$800K
Undisclosed Investor(s)
GrantEvent
May 2017
$56K
EU Horizon 2020
GrantEvent
Jun 2016
$700K
BIRD Foundation
GrantEvent
Dec 2015
$310K
Office of the Chief Scientist
MedAware News
10 articles
growth-positive
/PRNewswire/ -- Ballad Health, the leading healthcare provider in the Appalachian Highlands, has begun leveraging MedAware's AI-powered medication safety...
Ballad Health, a leading healthcare provider in the Appalachian Highlands, has integrated MedAwares AI-powered medication safety monitoring platform into its Epic pharmacy workflow. This partnership, announced in July 2023, aims to enhance patient safety by providing real-time, personalized risk monitoring for acute care patients. The platform allows pharmacists to proactively address medication-related risks, improving patient outcomes and operational efficiency. MedAwares technology has enabled Ballad Health to act on over 70% of identified patient risks, significantly surpassing previous systems. This collaboration highlights Ballad Healths commitment to innovation in rural healthcare and medication safety.
Partners
growth-positive
MedAware Validates an Emerging Risk to Patient Safety - Physician Burnout and Lack of Experience Linked to Prescription Errors
MedAware, a leader in AI-enabled decision support and patient safety solutions, released the results from a study showing that sleep-deprived, overworked junior physicians are at increased risk of erroneous prescribing and jeopardizing patient safety. The study highlights the need for AI-driven, personalized decision support to mitigate the risks of medication errors. MedAwares platform, which boasts an 85% accuracy rate, acts as a safety layer within electronic health records (EHRs) and detects outlier prescribing behavior. The study found that physicians with high workloads were 8 times more likely to make prescribing errors, and continuous back-to-back shifts were associated with 2 times the risk of error. MedAware emphasizes the importance of incorporating probabilistic and personalized decision support tools to improve patient safety.
Customers
growth-positive
Israeli tech catches medical mistakes before they happen
A machine learning-based patient safety solution from MedAware flagged potential errors and adverse drug events in the records of patients treated in outpatient clinics. The system performed well in identifying medication-related errors and implementing it could result in substantial cost savings. Prescription drug errors result in healthcare costs estimated at more than $20 billion annually in the United States.
Customers
growth-positive
Harvard Researchers Find Significant Clinical Impact and Savings with MedAware's Patient Safety Platform
MedAware, a developer of AI-based patient safety solutions, has published a study validating the clinical impact and cost savings of its machine learning-enabled clinical decision support platform. The study found that 70% of MedAwares AI-enabled clinical interventions would not have been generated by existing tools. If the system had been operational, it could have saved over $1.3 million in direct healthcare-related costs for adverse events potentially prevented in Massachusetts General and Brigham and Womens Hospitals outpatient clinics. The study analyzed outpatient data from two academic medical centers and found that MedAwares warnings were accurate, clinically valid, and would not have been flagged by existing decision support systems. The study highlights the potential of MedAwares platform to improve patient safety and drive cost savings in healthcare systems.
Customers
growth-positive
Assuta Ashdod Medical Center Deploys MedAware's Patient Safety Platform
MedAwares AI-based patient safety solution will be deployed in Assuta Ashdod, Israels newest hospital. The live implementation follows a successful trial deployment and will provide an essential layer of protection to prevent medical errors and faulty prescriptions. The system has been proven to be effective in identifying medication-related risks and preventing patient harm. MedAware aims to protect 100 percent of the Israeli population and transform patient safety globally.
Customers
growth-positive
MedAware Uses AI to Detect Potential Medication Errors: Interview with Dr. Gidi Stein, CEO
MedAware, an Israeli company, is using artificial intelligence to detect potential medical errors before they happen. The company aims to improve patient safety and prevent adverse drug events. MedAware is currently being used in hospitals in Israel and is in the process of being implemented in healthcare systems in the US and Israel. The company has partnered with Allscripts Healthcare Solutions, a major electronic medical records provider in the US. The biggest challenge for MedAware is convincing hospital executives to prioritize patient safety and invest in their technology. In the next five years, MedAware aims to expand its reach, improve accuracy, and provide additional ways to keep patients safe.
CustomersPartners
growth-positive
Sheba Medical Bolsters Patient Safety Practices With MedAware®'s Medication Safety Platform
MedAware, a developer of AI-based patient safety solutions, has announced the successful implementation of its medication safety platform at Sheba Medical Center. The platform uses big data analytics and machine learning algorithms to identify potential dangerous medication outliers with high accuracy and low alert fatigue. The implementation has resulted in high physician acceptance rates, safer patient care, and improved clinical outcomes. Sheba Medical Center, the largest and most comprehensive medical center in the Middle East, has decided to roll out the MedAware program across the entire hospital. MedAwares technology has been proven to be effective in reducing medication errors and improving patient safety.
Customers
growth-positive
MedAware and Allscripts Partner to Enhance Patient Safety and Usher in a New Era of Meaningful Interoperability
MedAware is partnering with Allscripts Healthcare Solutions to provide safer prescribing and medication management solutions to Allscripts customers. MedAwares AI-based technology monitors patients clinical records to detect medication-related risks and adverse drug events, providing actionable insights at the point of care. The partnership will leverage data and technology to improve patient care and help curb the opioid epidemic. MedAwares clinical monitoring technology, powered by machine learning algorithms, identifies potentially life-threatening prescriptions that are in conflict with the patients profile. This collaboration is a significant milestone for MedAware and will contribute to the companys growth.
Partners
growth-positive
MedAware Raises $8 Million in Series A Funding to Eradicate Catastrophic Prescription Errors
MedAware, a provider of algorithm-rich solutions for the detection and elimination of prescription errors, has raised $8 million in Series A funding. The companys total funding raised to date is $12 million. The funding will be used to advance the companys approach to identifying medication mistakes, improving patient safety and saving lives. MedAware uses machine-learning algorithms to detect outliers in prescription behavior and flag them as life-threatening. The company plans to enhance its offering, develop additional machine learning-enabled decision support solutions, and expand its North American footprint and EMR integrations in the United States. MedAware has already demonstrated success in the United States and has received validation from a Harvard Medical School research study.
Investment
growth-positive
An Israeli cure for Rx errors
MedAware, an Israeli start-up, has developed a Prescription Analysis and Alert System to prevent prescription errors, which are estimated to cause injuries and deaths of more than 200,000 patients every year in the US alone. The technology uses big-data analytics of electronic medical records data to learn prescription patterns used by physicians and identify potential prescription errors in real time. The system is to be installed in Sheba Medical Center, Israels largest hospital, and pilot studies are being conducted at Bostons Brigham and Womens Hospital and Massachusetts General Hospital.
CustomersInvestmentPartners
MedAware Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 27 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 13 classification IDs that could be used for matching.
MedAware Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 101/100 |
| Missing | markets |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 514760305 |
| Crunchbase | medaware |
| Phone | +97297404939 |
| Creator | Tami Gaoni Feldman |
| Creator email | tami.gaoni@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2022-11-24T00:00:00.000Z |
| Created | 2014-06-24T00:00:00.000Z |
| Claimed | Yes |